Business Wire

Bynder Kicks Off Peak Shopping Season by Serving a Record 6 Billion Assets - Powering Exceptional Global Content Experiences Online

9.12.2024 16:07:00 CET | Business Wire | Press release

Share

Bynder, a global leader in AI-powered enterprise DAM, has helped a number of global brands break Black Friday and Cyber Monday records by delivering exceptional content experiences at scale across a number of worldwide e-commerce channels.

During the seven day period (November 27 - Dec 2 2024) which included Black Friday, Small Business Saturday, and Cyber Monday, Bynder’s Content Experiences (CX) for Omnichannel solution was responsible for serving more than 6 billion assets to over 70,000 websites, with more than 4.5 billion asset transformations undertaken.

The figures represent a 15% increase in assets delivered vs 2023, plus 67% more assets were delivered through CX for Omnichannel on Black Friday than an average day in 2024.

Customers such as Sur La Table, Bose, Raymour & Flanigan and Puma used CX for Omnichannel to deliver targeted and optimized content at scale to their digital channels over the busiest shopping days. Bynder customers were able to utilize the assets stored in their Bynder DAM and transform and deliver them to their digital channels, including their website, e-commerce sites, emails and social media.

Bynder’s DAM sits at the heart of a brand’s martech stack as the system of record for digital assets, while Bynder’s CX for Omnichannel solution is the delivery technology that connects the DAM to a brand’s tech ecosystem and automates delivering optimized assets for each digital channel in real time.

For consumer brands that are delivering seasonal shopping content across a number of e-commerce platforms, Bynder’s solution can transform, optimize and deliver targeted content experiences based on the channel and audience automatically, that boost return on investment all while ensuring brand consistency, improved website performance and increase in conversions for e-commerce sites.

According to a NielsenIQ study analyzed by Barcelona's OBS Business School, Black Friday has become one of the most anticipated European retail periods in the run-up to the holiday season, with 61% of consumers in Spain, the UK, Italy, France, and Germany expected to have participated in Black Friday. While in the US, a record 200.4 million consumers shopped over the five-day holiday weekend from Thanksgiving Day through Cyber Monday, surpassing last year’s record of 196.7 million.

When creating and managing seasonal assets, a survey by Bynder revealed that 51% of marketers agreed that more marketing assets are required for Black Friday than any other seasonal holiday. The biggest challenge stated for just over one in three (36%) respondents was managing the number of assets they were creating for the peak shopping season.

Sur La Table, a retailer known for a variety of upscale cooking and dining supplies, is one such brand scaling its content delivery through Bynder during the holiday peak period.

Blake Bakanoff, VP of Creative at Sur La Table, said, “A good tool improves the way we work. A great partner improves the way we think, make and move.At Sur La Table, bringing value to our customers, by creating exceptional culinary content, lies at the core of our brand. We’re “Makers” at heart, and Bynder’s CX for Omnichannel solution empowers us to create, adapt, and deliver a wealth of custom content tailored to every channel—whether it’s showcasing thoughtful gift ideas on Instagram, sharing original holiday recipes through email, or engaging customers as they explore our website. By connecting our teams and external partners to our extensive content catalog delivering 165M+ assets, Bynder enables us to inspire and delight our customers with curated, memorable experiences during the peak holiday season."

Peter-Paul Houtman, CTO at Bynder, said: “The period between Thanksgiving and Cyber Monday represents some of the busiest days for e-commerce retailers. The volume of shoppers has increased over time and so has the volume of products that are available at a discount. E-commerce retailers are dealing with a higher volume of transactions and they need a scalable AI-powered enterprise grade platform like Bynder’s DAM, as well as its Content Experiences (CX) for Omnichannel solution, to deliver exceptional content experiences for their customers during these peak times.

“A unified omnichannel approach in terms of managing assets and delivering assets digitally ensures no opportunity is missed during peak retail seasons and by using Content Experiences for Omnichannel, leading brands can supercharge their marketing strategies and boost engagement by creating targeted content experiences across a number of digital touchpoints, improving website performance and conversions to bring real return-on-investment to businesses.”

For more information on Bynder’s DAM, please visit: https://www.bynder.com/en/products/digital-asset-management/ and for more information on Content Experiences (CX) for Omnichannel, please visit: https://www.bynder.com/en/products/content-experiences-for-omnichannel/

View source version on businesswire.com: https://www.businesswire.com/news/home/20241209828157/en/

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Incyte Announces New Positive 54-Week Late-Breaking Data for Povorcitinib in Hidradenitis Suppurativa at the 2026 American Academy of Dermatology (AAD) Annual Meeting28.3.2026 20:00:00 CET | Press release

Phase 3 data from the STOP-HS program demonstrate povorcitinib’s substantial and durable clinical efficacy through Week 54 in patients with moderate to severe hidradenitis suppurativa (HS). Through Week 54, clinically meaningful and durable responses were observed across all groups in both STOP-HS1 and STOP-HS2, with up to 71.4% of patients achieving HiSCR50. Improvements in clinical responses across high stringent thresholds were observed, with up to 57% of participants achieving HiSCR75 and up to 29% of participants achieving HiSCR100. Povorcitinib treatment led to consistent reductions across key inflammatory lesion types, with full resolution (ANdT=0) achieved in up to 20% of patients. Additionally, clinically meaningful improvements in quality-of-life measures, including skin pain and fatigue, were observed at Week 54. The overall safety profile of povorcitinib through 54 weeks is consistent with previously reported data, and both doses were well tolerated. Incyte (Nasdaq:INCY) to

Takeda’s Zasocitinib Delivered Rapid and Durable Skin Clearance in a Convenient Once-Daily Pill, Affirming Promise to Reshape Psoriasis Care28.3.2026 20:00:00 CET | Press release

About 70% of patients treated with zasocitinib achieved clear or almost clear skin (sPGA 0/1) at week 16 in Phase 3 plaque psoriasis studies A significantly greater PASI 75 response rate versus placebo was observed as early as week 4 Safety profile consistent with Phase 2b studies with no new safety signals identified Takeda(TSE:4502/NYSE:TAK)today announced new data from the two pivotal Phase 3studies of zasocitinib (TAK-279), a next-generation, highly selective oral tyrosine kinase 2 (TYK2) inhibitor, in adults with moderate-to-severe plaque psoriasis (PsO).1 Presented as a late-breaking abstract at the 2026 American Academy of Dermatology (AAD) Annual Meeting, these data show that convenient once-daily oral zasocitinib demonstrated rapid and durable skin clearance with a safety profile consistent with Phase 2b studies.1,2 “Our goal in psoriasis treatment is clear or almost clear skin, and previously this has been achieved primarily with injectable therapies,” said Melinda Gooderham,

AAD 2026: Late-Breaking Nemolizumab Data Demonstrate Clinically Meaningful Benefits for Children Aged 2 to 11 With Moderate-to-Severe Atopic Dermatitis28.3.2026 16:00:00 CET | Press release

Pharmacokinetics, safety and efficacy clinical study data show that nemolizumab achieved clinically meaningful reductions in skin lesions and itch through Week 16, which were sustained up to a year in children aged 2 to 11 with moderate-to-severe atopic dermatitis1 These findings reinforce the previously established safety and efficacy of nemolizumab in adults and adolescents with moderate-to-severe atopic dermatitis, for which it is approved by multiple global regulatory authorities2,3 Up to 25% of children are affected by atopic dermatitis, and currently there are limited approved treatment options for children living with moderate-to-severe atopic dermatitis4,5 Galderma (SIX: GALD) today announced new phase II data showing that nemolizumab was well tolerated and effective in children (aged 2 to 11 years) with moderate-to-severe atopic dermatitis, with a clinically meaningful and sustained reduction in skin lesions and itch for up to a year.1 Results will be presented in a late-break

Angelalign Technology (6699.HK)Releases 2025 Results: Passion for Clinical Excellence Drives Worldwide Growth27.3.2026 20:56:00 CET | Press release

Angelalign Technology Inc. (6699.HK) (“Angel” or the “Company”) released its financial results for fiscal year 2025. During the reporting period, the Company continued to do well in both the global and China markets. Total case volume was 532,400, which increased 48.1%, revenue was USD 370.3 million, which increased 37.8%, and adjusted net profit was USD 43.8 million, which increased 63.0%. The results were driven by Angel’s passion for clinical excellence and its open and inclusive culture that empowers talented people to work together to meet customer needs, the Company said. Fox Hu, CEO of Angel, stated: “The clear aligner industry is complex and multidisciplinary. It requires top-tier technical and operational talent along with seamless collaboration among professionals from diverse geographies. Angel’s open and inclusive culture attracts professionals who share a passion for clinical excellence and a dedication to bringing outstanding products and services to customers. This melti

Axway Positioned as a Leader in the IDC MarketScape: Worldwide API Management 2026 Vendor Assessment27.3.2026 18:46:00 CET | Press release

Axway, a 74Software company (Euronext: 74SW) and global leader in federated API management and enterprise integration, has been named a Leader in the IDC MarketScape: Worldwide API Management 2026 Vendor Assessment.1 Axway Amplify securely connects, orchestrates, and automates data integration. Organizations in financial services, manufacturing, healthcare, and other industries rely on Amplify to modernize integrations and confidently unlock data to deliver superior digital services faster. The report notes: “The platform benefits from Axway’s long-standing experience in B2B integration, secure file transfer, and legacy connectivity, providing differentiated capabilities for organizations that need to expose and control APIs around core systems that are not cloud-native.”1 This multi-pattern expertise in security, integration, and federated governance — built during the early phases of the API-driven digital transformation — becomes especially critical as enterprises seek to govern dat

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye